SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-010231
Filing Date
2022-02-01
Accepted
2022-02-01 14:30:14
Documents
3
Group Members
AEQUANIMITAS LIMITED PARTNERSHIPISIDORO QUIROGA MORENOSOUTH CONE INVESTMENTS LIMITED PARTNERSHIPSOUTH LAKE MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tm225035d1_sc13da.htm SC 13D/A 110806
2 EXHIBIT 99.1 tm225035d1_ex99-1.htm EX-99.1 53513
3 EXHIBIT 99.2 tm225035d1_ex99-2.htm EX-99.2 20931
  Complete submission text file 0001104659-22-010231.txt   186970
Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 56227989600
South Lake One LLC (Filed by) CIK: 0001794292 (see all company filings)

IRS No.: 371948818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Subject) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92761 | Film No.: 22578331
SIC: 2834 Pharmaceutical Preparations